• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Intracerebral hemorrhage risk factors and risk factor burden may differ across racial groups

byJake EngelandMichael Pratte
August 27, 2021
in Emergency, Imaging and Intervention, Neurology, Public Health
Reading Time: 3 mins read
Small-molecule inhibitor may enhance recovery after brain hemorrhage [PreClinical]
Share on FacebookShare on Twitter

1. Risk factors for intracerebral hemorrhage (ICH), such as hypertension (treated and untreated) and lack of medical insurance, disproportionately burdened Black and Hispanic individuals over White individuals.

2. Sleep apnea may be a potential new risk factor for lobar and nonlobar ICH.

Evidence Rating Level: 3 (Average)

Study Rundown: Intracerebral hemorrhage (ICH) is a type of stroke that carries a high mortality rate. Recent evidence suggests that Blacks and Hispanics have a higher risk of ICH compared to Whites. This prospective, case-control study evaluated the prevalence, odds ratio, and population attributable risk (PAR) of known and novel risk factors of ICH; these risk factors were assessed across ICH type, location, and racial group (White, Hispanic, and Black individuals). Firstly, ICH occurred at a significantly younger age among Black and Hispanic patients compared to White patients (approximately ten years earlier). Among established risk factors for ICH, treated and untreated hypertension and a lack of health insurance were more often associated with ICH development in Black and Hispanic patients than White ones. The APOE e2 and APOE e4 alleles were associated with higher risk for lobar ICH in Whites, but not in Black or Hispanic individuals. Unexpectedly, hypercholesterolemia was associated with a reduced risk for ICH, even though it is a well-established risk factor for cardiovascular disease. Notably, obstructive sleep apnea (OSA) was a new risk factor for ICH, which was observed across all three racial groups. Overall, this study presented both established and unknown risk factors for ICH and demonstrated how the burden of certain risk factors, such as hypertension and lack of health insurance, affect some racial groups more than others. One limitation, however, is that the nature of this study (case-control) does not allow causal relationships to be established between risk factors and ICH.

Click to read the study in JAMA Network Open

Relevant Reading: The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics

RELATED REPORTS

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

2 Minute Medicine Rewind August 17, 2026

Triple low-dose antihypertensive pill reduced recurrent stroke after intracerebral hemorrhage

In-Depth [case-control study]: This multicentre, prospective study recruited 1000 ICH participants from three races (White, Black, and Hispanic) and 1000 control participants from each group to total 6000 participants. Participants were enrolled from 42 United States hospitals from September 2009 to July 2016. The primary outcomes were prevalence, odds ratios, and PARs for each risk factor, stratified among racial groups and ICH types. Hypertension is a significant risk factor for ICH. Among Black and Hispanic participants, PAR percentages for treated hypertension were 53.6% (95% CI: 46.4-59.8) and 46.5% (95% CI: 40.6-51.8), respectively; in comparison, White participants had a PAR percentage of 26.3% (95% CI: 17.8-33.8). Additionally, PAR percentages among Black and Hispanic patients for untreated hypertension were also higher compared to their White counterparts. PAR percentages for lack of medical insurance were 21.7% (95% CI: 17.0-25.7), 30.2% (95% CI: 26.1-34.1), and 5.8% (95% CI: 3.3-8.2) among Black, Hispanic, and White patients, respectively. High sleep apnea risk demonstrated an overall OR of 1.68 (95% CI: 1.36-2.06) and 1.62 (95% CI: 1.37-1.91) for lobar ICH and nonlobar ICH, respectively.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: intracerebral hemorrhageintracranial hemorrhage (ICH)racial differencesracial disparities
Previous Post

Hormone therapy may have an important impact on performance in transgender athletes

Next Post

#VisualAbstract PEITHO-2 shows that switching from heparin to dabigatran early in patients with acute intermediate-risk pulmonary embolism is safe and effective

RelatedReports

No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

August 18, 2026
Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males
Weekly Rewinds

2 Minute Medicine Rewind August 17, 2026

August 17, 2026
Combined MRI and NIH stroke scores may predict stroke prognosis
Cardiology

Triple low-dose antihypertensive pill reduced recurrent stroke after intracerebral hemorrhage

May 4, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Early control of systolic blood pressure following intracerebral hemorrhage may improve functional recovery

March 24, 2026
Next Post
#VisualAbstract PEITHO-2 shows that switching from heparin to dabigatran early in patients with acute intermediate-risk pulmonary embolism is safe and effective

#VisualAbstract PEITHO-2 shows that switching from heparin to dabigatran early in patients with acute intermediate-risk pulmonary embolism is safe and effective

Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure

VieScope as a comparable alternative to Macintosh and Glidescope laryngoscopy for securing difficult airways

Reduced gestational weight gain with lifestyle intervention

Health wearable devices effectively promote bodyweight in overweight/obese individuals

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases
  • The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality
  • Alcohol use declines but remains above pre-pandemic levels
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.